El impacto de los canales digitales y redes sociales en la promoción de medicamentos. Panorama normativo y nuevas herramientas de Control

Social media and digital channels have established themselves as a regular means of information dissemination for the industry. This scenario creates new challenges for companies’ compliance with the regime for promotion of medicinal products, such as the difficulty of controlling the final recipient of the information or the possibility for individual internet users to generate content. To face these challenges, this article reviews the regulatory framework relating to the use of these media in order to help companies to prepare guidelines for the use of digital channels and control and liability procedures.